Literature DB >> 30517029

HMGB1 is mechanistically essential in the development of experimental pulmonary hypertension.

Mao Dai1,2, Rui Xiao1,2, Luyao Cai1,2, Tong Ge1,2, Liping Zhu1,2, Qinghua Hu1,2.   

Abstract

Pulmonary hypertension (PH) is a mortal disease featuring pulmonary vascular constriction and remodeling, right heart failure, and eventual death. Several reports showed that high-mobility group box 1 (HMGB1) appears to be critical for the development of PH; the underlying mechanism, however, has not been revealed. Experiments in the present study demonstrated that HMGB1 levels were elevated in the lung tissue and blood plasma of rats after chronic hypoxia exposure and monocrotaline treatment. HMGB1 was originally located within the nucleus and translocated to the cytoplasm of pulmonary artery smooth muscle cells (PASMCs) upon hypoxia exposure, a process that appeared to be mediated by endogenous H2O2. Exposure to HMGB1 mobilized calcium signaling in PASMCs, a response that was attenuated by extracellular Ca2+ removal, Toll-like receptor 4 (TLR4) inhibition by TAK-242, or transient receptor potential channel (TRPC) suppression with 2-aminoethoxydiphenyl borate (2-APB) and SKF-96365. The sustained phosphorylation of the Akt pathway modulated HMGB1-induced migration of PASMCs. The blockage of HMGB1 with glycyrrhizin or anti-HMGB1 neutralizing antibody attenuated lung inflammation and PH establishment in rats after hypoxia exposure and monocrotaline treatment. The above findings reveal the mechanistic importance of HMGB1 in PH through TLR4- and TRPC-associated Ca2+ influx and Akt phosphorylation-driven PASMC migration.

Entities:  

Keywords:  HMGB1; PI3K/Akt; TLR4; calcium; migration; pulmonary hypertension

Mesh:

Substances:

Year:  2018        PMID: 30517029     DOI: 10.1152/ajpcell.00148.2018

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  10 in total

1.  Necrosis-Released HMGB1 (High Mobility Group Box 1) in the Progressive Pulmonary Arterial Hypertension Associated With Male Sex.

Authors:  Marina Zemskova; Nolan McClain; Maki Niihori; Mathews V Varghese; Joel James; Ruslan Rafikov; Olga Rafikova
Journal:  Hypertension       Date:  2020-10-05       Impact factor: 10.190

2.  Exercise Training Attenuates Hypertension Through TLR4/MyD88/NF-κB Signaling in the Hypothalamic Paraventricular Nucleus.

Authors:  Jie Qi; Xiao-Jing Yu; Li-Yan Fu; Kai-Li Liu; Tian-Tian Gao; Jia-Wei Tu; Kai B Kang; Xiao-Lian Shi; Hong-Bao Li; Ying Li; Yu-Ming Kang
Journal:  Front Neurosci       Date:  2019-10-24       Impact factor: 4.677

3.  Sex-specific stress response and HMGB1 release in pulmonary endothelial cells.

Authors:  Marina Zemskova; Sergey Kurdyukov; Joel James; Nolan McClain; Ruslan Rafikov; Olga Rafikova
Journal:  PLoS One       Date:  2020-04-09       Impact factor: 3.240

4.  Lung damage created by high tidal volume ventilation in rats with monocrotaline-induced pulmonary hypertension.

Authors:  Masako Kawai; Erquan Zhang; Jane Chanda Kabwe; Amphone Okada; Junko Maruyama; Hirofumi Sawada; Kazuo Maruyama
Journal:  BMC Pulm Med       Date:  2022-03-05       Impact factor: 3.317

Review 5.  Epigenetic Regulation of Endothelial Dysfunction and Inflammation in Pulmonary Arterial Hypertension.

Authors:  Jaylen Hudson; Laszlo Farkas
Journal:  Int J Mol Sci       Date:  2021-11-09       Impact factor: 5.923

6.  Model difference in the effect of cilostazol on the development of experimental pulmonary hypertension in rats.

Authors:  Toshikazu Ito; Erquan Zhang; Ayaka Omori; Jane Kabwe; Masako Kawai; Junko Maruyama; Amphone Okada; Ayumu Yokochi; Hirofumi Sawada; Yoshihide Mitani; Kazuo Maruyama
Journal:  BMC Pulm Med       Date:  2021-11-20       Impact factor: 3.317

7.  Endothelial cell ferroptosis mediates monocrotaline-induced pulmonary hypertension in rats by modulating NLRP3 inflammasome activation.

Authors:  Shan-Shan Xie; Yan Deng; Sheng-Lan Guo; Jia-Quan Li; Ying-Chuan Zhou; Juan Liao; Dan-Dan Wu; Wei-Fang Lan
Journal:  Sci Rep       Date:  2022-02-23       Impact factor: 4.379

8.  Upregulation of IRF9 Contributes to Pulmonary Artery Smooth Muscle Cell Proliferation During Pulmonary Arterial Hypertension.

Authors:  Yong-Jie Chen; Yi Li; Xian Guo; Bo Huo; Yue Chen; Yi He; Rui Xiao; Xue-Hai Zhu; Ding-Sheng Jiang; Xiang Wei
Journal:  Front Pharmacol       Date:  2021-12-01       Impact factor: 5.810

9.  Analysis of necroptosis and its association with pyroptosis in organ damage in experimental pulmonary arterial hypertension.

Authors:  Izabela Jarabicová; Csaba Horváth; Eva Veľasová; Lenka Bies Piváčková; Jana Vetešková; Ján Klimas; Peter Křenek; Adriana Adameová
Journal:  J Cell Mol Med       Date:  2022-04-07       Impact factor: 5.295

10.  Involvement of Toll-Like Receptor 4 in Decreased Vasopressor Response Following Trauma/Hemorrhagic Shock.

Authors:  Rafi Mazor; Fernando Dos Santos; Joyce B Li; Federico Aletti; Geert Schmid-Schonbein; Erik B Kistler
Journal:  Crit Care Explor       Date:  2021-07-06
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.